Eric Wei, Director at Caladrius Biosciences, Inc. (CLBS), sold 8,425 shares at $4.51 ($39K) on 2017-02-02, disclosed to the SEC on 2017-02-06.
Scheduled sale ($39k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.51 | 5,000 | $23K | 58.1% |
| 2 | $4.75 | 1,400 | $7K | 17.1% |
| 3 | $4.76 | 1,525 | $7K | 18.7% |
| 4 | $4.75 | 500 | $2K | 6.1% |
| Total | $4.61 avg | 8,425 | $39K | 100% |
| Filing → |
| CCCS | SELL | 2025-05-22 | $544.8M | — | Filing → |
| CCCS | SELL | 2025-03-04 | $867.7M | — | Filing → |
| CCCS | SELL | 2024-07-01 | $564.4M | — | Filing → |